Kenalog of No Benefit to Photodynamic Therapy
November 22, 2009
Submit Comments
For those rare circumstances where Photodynamic Therapy (PDT) is performed (it would seem anti-VEGF is appropriate for 99% of cases, except where the CNV is small and peripheral), an article in Ophthalmology reports that injecting Kenalog offered no additional benefit.
You might also enjoy...
- Do Anti-VEGF Injections Increase the Risk of Stroke or Heart Attack?
- An Overview of Current Anti-VEGF Protocols for AMD
- FDA Grants NeoVista’s Request to Utilize Novel Wet AMD Treatment in Compassionate Case
- Does Photodynamic Therapy Add Anything to Anti-VEGF Treatments?
- Another Bad Day for Intravit Kenalog for Diabetic Macular Edema
Comments
Jump down to form below to submit your own comments
